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Case Presentation

A 67 year-old Cantonese speaking male was seen at primary care
clinic with complaints of dyspnea on exertion and decreased
exercise tolerance. His medical history includes rheumatic
heart disease, tricuspid regurgitation, tricuspid repair three
months ago, mitral regurgitation, mitral valve replacement with
a bioprosthetic valve three months ago, atrial fibrillation on
anticoagulation therapy, permanent pacemaker implantation,
severe pulmonary hypertension, benign prostatic hypertrophy,
gastroesophageal reflux disease, and iron deficiency anemia.
The patient reports that in the last two weeks, he has been
unable to ambulate more than two blocks limited by shortness
of breath, which represents an acute change. He also complains
of bilateral lower extremity edema. He reports that two weeks
after his mitral valve replacement, his exercise tolerance was
dramatically improved, and he was able to ambulate more than
two blocks without difficulty.
He denies associated cough, lightheadedness, dizziness, chest
discomfort, abdominal discomfort, nausea or vomiting. He
reports occasional palpitations that are not associated with his
episodes of dyspnea on exertion. Dyspnea resolves with rest in
minutes. He denies recent fevers, sweats, and chills. Medications
include metoprolol 25 mg twice a day, warfarin 4 mg daily,
furosemide 40 mg daily, enteric-coated aspirin 81 mg daily,
sustained-release potassium chloride 20 mEq daily, ferrous
sulfate 300 mg three times per day, colace 100 mg twice per day,
sennosides 8.6 mg daily and omeprazole 20 mg daily
On physical examination, the patient was alert and oriented to
person, place, and time and not in acute distress, afebrile, with
a heart rate of 76 beats/minute, blood pressure of 90/60 mm
Hg, respiratory rate 14 breaths/minute. Pupils were equal and
reactive to light, and extraocular muscles were intact. There
were no carotid bruits bilaterally, and jugular venous pressure
was estimated at 16 cm of water. His lungs were clear to
auscultation bilaterally with no wheeze, no crackles, nor rales.
Cardiac exam demonstrated a midline sternal surgical scar,
an irregularly irregular heart rhythm, no murmurs, gallops,
nor rubs. Abdominal exam demonstrated a soft, nontender,
nondistended abdomen with normoactive bowel sounds and
no organomegaly. His extremities did not demonstrate lower
extremity edema, clubbing, or cyanosis, and his pulses were 2+
radial, 2+ femoral, and 2+ dorsalis pedis bilaterally. Neurologic
exam did not reveal any focal deficits.
Electrocardiogram demonstrated atrial fibrillation with a
ventricular response rate of 90 beats per minute, normal axis,
peaked T waves, and no acute changes suggestive of ischemia.
Routine basic metabolic panel done five days prior to his office
visit was remarkable for a potassium of 5.0 mEq/L.
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The patient also had an appointment with his cardiologist
for evaluation of his symptoms. After the evaluation he was
admitted directly to hospital for further evaluation of his new
symptoms of congestive heart failure. His admission labs were
unremarkable with the exception of B-type natriuretic peptide
of 1463 pg/mL. His admission chest x-ray was suggestive of a
left pleural effusion, cardiomegaly and pulmonary edema.
Transthoracic echocardiogram revealed the bioprosthetic valve
in the mitral position had its ventricular side tilted toward the
interventricular septum. There was no evidence of rocking of the
mitral prosthesis. The peak mitral valve gradient was 13 mm of
Hg. The mean transmitral valve gradient was 4 mm of Hg. The
estimated mitral valve area was 2.6 cm2 which is described as
normal in the setting of a prosthetic valve. There was a moderate
paravalvular regurgitant leak between the prosthesis and lateral
wall of the left ventricle (LV). The effective regurgitant orifice
area of the paravalvular leak is estimated at 0.33 cm2. There was
evidence of mild aortic regurgitation, mild left atrial enlargement
and an overall severely decreased LV systolic function with
segmental wall motion abnormalities. The distal half of the LV
is akinetic. The proximal walls were severely hypokinetic. LV
ejection fraction was estimated to be 20%, and there was right
ventricular (RV) enlargement with decreased function. There
was no evidence of vegetations on the valves or pacemaker leads.
Compared with an echocardiogram done one month following
replacement, of his mitral valve, there was interval deterioration
of LV function. The paravalvular leak appeared unchanged.
Computed tomography of the thorax without contrast
demonstrated an irregular consolidation in right upper lobe
which was indeterminate, but most likely represented atelectasis
and/or pneumonitis, bilateral pleural effusions, a left lower
lobe consolidation and an enlarged left heart post mitral and
tricuspid valvular repair.
Cardiothoracic surgery was consulted. Due to the malpositioning of the prosthetic valve and evidence of worsening
ventricular function, it was decided that the patient would need
another operation to replace his prosthetic mitral valve.

Discussion

Heart valve surgery is still considered one of the most important
advances in patients with symptomatic, severe valvular heart
disease.1 Annually, there are an estimated 42,000 mitral valve
procedures in the United States.2 It is important to appreciate
that replacement of a diseased valve is not a cure for the valvular
disease process, but rather an exchange of the native disease
for a new set of complications that are associated to the new
valve prosthesis.3,4 For this reason, the frequency and intensity
of follow up and evaluation of prosthetic valves is similar to
the follow up of newly diagnosed native valve disorders. The
American College of Cardiology (ACC) and the American
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there is any change in clinical status or development of new
symptoms. An echocardiogram is indicated in any patient
whenever there is evidence of a new murmur or change in
clinical status, when there are questions about prosthetic
valve integrity and function, and when there are concerns
about ventricular function. If the patient develops valvular
regurgitation, close follow up with echocardiography every
three to six months is indicated.
Patients who do not improve after surgery or who later show
deterioration of functional capacity should be evaluated
with an echocardiogram and, if necessary, transesophageal
echocardiography and cardiac catheterization with
angiography to determine the cause.

Figure 1. The patient’s chest radiograph shows cardiomegaly,
pulmonary vascular congestion, developing consolidation in
left lower left lower lobe, a left-sided dual chamber pacemaker,
midline sternotomy wires, and evidence of a tricuspid
annuloplasty ring.
Heart Association (AHA) Task Force recommends the following
guidelines for evaluation and management of patients after
valve replacement:3
The first postoperative outpatient evaluation should be
two to four weeks after hospital discharge. By this time, the
patient’s physical capabilities and expected improvement in
functional capacity can be assessed. The focus of this initial
evaluation is to assess for infection and myocardial infarction,
an assessment of function of the prosthetic valve, electrical
conduction and other valvular disorders. Follow up should
include an interval post-op history, physical examination,
an electrocardiogram, complete blood count, electrolytes,
an INR as indicated for management of anticoagulation
therapy and a transthoracic Doppler echocardiogram.
Echocardiography can provide information about
prosthesis stenosis or regurgitation, valve area, pulmonary
hypertension, LV or RV hypertrophy, LV and RV size and
function, pericardial effusion and thickening, perivalvular
regurgitation and assess function of the other heart valves.
This initial echocardiogram is important to establish
baseline characteristics of the prosthetic valve if one was
not yet done prior to discharge.
Follow up of asymptomatic patients should be conducted
annually. No further echocardiographic testing is required
after the initial postoperative evaluation in patients who are
stable and do not have symptoms or clinical evidence of LV
dysfunction, prosthetic valve dysfunction, or dysfunction
of other heart valves. Reevaluations should be conducted if

Prosthetic heart valves are associated with a number of
complications including structural failure or deterioration, valve
obstruction from thrombosis, systemic embolization, bleeding,
endocarditis, impaired LV systolic function, hemolytic anemia,
and other infections. Perivalvular leakage, a form of structural
failure, is common. Severe perivalvular regurgitation maybe
inaudible on physical exam. Most are detected intraoperatively during the original valve surgery. Rates are reported to
be between 18 to 48%.5,6 The majority of perivalvular leaks are
trivial and are not clinically significant and do not progress.5,6
Our patient’s work up revealed that not only was his prosthetic
mitral valve malpositioned, but also his echocardiogram showed
an interval decline in his left ventricular systolic function three
months after operation.
Re-operation to replace a prosthetic heart valve is a considered
serious clinical event. The ACC/AHA Task Force recommends
re-operation for moderate to severe prosthetic dysfunction
(structural and nonstructural), dehiscence, and prosthetic
endocarditis. Other indications include patients who have
recurrent thromboembolism, severe intravascular hemolysis,
severe recurrent bleeding from anticoagulant therapy, and
thrombosed prosthetic valves. Stable patients without prosthetic
valve endocarditis under many circumstances who requires
reoperation are only slightly greater operative risk compared
to the risk of the initial surgery. In patients with catastrophic
prosthetic valvular dysfunction, surgery is clearly indicated
and urgent. Patients without endocarditis or severe prosthetic
valve dysfunction require careful hemodynamic evaluation,
and the decision about reoperation should then be based on
hemodynamic abnormalities, symptoms, ventricular function,
and the natural history of the particular prosthesis.3
In summary, patients who undergo mitral valve replacement for
treatment of their disease are not completely cured of valvular
heart disease and must be followed with the same care as
patients with native valve disease.7 A number of post-operative
complications are common and may develop early or late in
the post-operative period. The ACC/AHA Task Force on the
management of valvular heart disease recommends close annual
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evaluation and a baseline echocardiogram initially to monitor
valve structure and function. Though patients generally follow
up with subspecialists for evaluation of their prosthetic valves,
our patient sought all of this medical and post-operative care
with his primary care physician because of because of language
and cultural barriers. It is therefore critical that primary care
physicians also recognize the signs and symptoms of the serious
complications related to prosthetic valves.

Hospital Course

On day five of his hospital course, the patient was brought to the
operating room for a replacement of his prosthetic valve. It was
discovered that the patient had three major defects. The first was
a 0.5 cm defect near the mitral-aortic continuity with the surgical
pledgets having torn through the annulus with subsequent
partial dehiscence of the prosthetic mitral valve. The tissue
around the dehiscence was friable and could not be repaired.
The prosthesis was excised and replaced. The second defect was
a linear tear below the left coronary cusp of the aortic valve that
disrupted the aortic ventricular continuity. The defect could not
be repaired and thus was also replaced. Lastly, the third defect
was a tear of the pericardium which was repaired using a sheet
of bovine pericardium. Intraoperatively, the patient continued
to have significant bleeding from behind the aortic root and
was treated with various hemostatic agents including Biogel
and Surgicel. He required multiple vasoactive medications and
required multiple units of blood products but continued to be
hemodynamically unstable with a pressure of 55/30 and a heart
rate of 60 beats per minute. His cardiac rhythm on telemetry
demonstrated multiple episodes of ventricular tachycardia. His
condition and gravely poor prognosis was discussed with his
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family, and it was decided that the medical team would halt all
attempts at cardiac resuscitation. The patient expired shortly
after with his family at his bedside.
His family consented to an autopsy which revealed evidence of
rheumatic heart disease, RV and LV dilatation and hypertrophy,
and left atrial dilatation. His lungs had signs of acute and
chronic passive congestion. Interestingly, there were histological
signs of adenocarcinoma in his prostate. His final cause of
death was determined to be due to pericardial and mediastinal
hemorrhage status post open heart surgery for mitral and aortic
valve replacement.
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